KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Restructuring Costs (2021 - 2025)

LifeMD (LFMD) has disclosed Restructuring Costs for 3 consecutive years, with $8.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Restructuring Costs rose 16.74% year-over-year to $8.8 million, compared with a TTM value of $32.0 million through Dec 2025, up 16.08%, and an annual FY2025 reading of $32.0 million, up 16.08% over the prior year.
  • Restructuring Costs was $8.8 million for Q4 2025 at LifeMD, up from $3.9 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $18.1 million in Q2 2025 and bottomed at $45659.0 in Q1 2022.
  • Average Restructuring Costs over 3 years is $6.6 million, with a median of $6.3 million recorded in 2024.
  • Peak annual rise in Restructuring Costs hit 88.34% in 2025, while the deepest fall reached 79.85% in 2025.
  • Year by year, Restructuring Costs stood at $45659.0 in 2022, then surged by 16386.31% to $7.5 million in 2024, then rose by 16.74% to $8.8 million in 2025.
  • Business Quant data shows Restructuring Costs for LFMD at $8.8 million in Q4 2025, $3.9 million in Q3 2025, and $18.1 million in Q2 2025.